Ascendis Pharma A/S (NASDAQ:ASND) Q1 2023 Earnings Call Transcript April 27, 2023
Ascendis Pharma A/S beats earnings expectations. Reported EPS is $-1.98, expectations were $-2.66.
Operator: Thank you for standing by and welcome to the Q1 2023 Ascendis Pharma Earnings Conference Call. At this time, all participants are in a listen-only mode. After the speakers’ presentation, there will be a question-and-answer session As a reminder today’s call is being recorded. I would now like to turn the...
